Study published confirming intraaortic balloon pumps as the clinically and economically cost-effective first line choice for high-risk PCI patients

Maquet Cardiovascular USA has announced the publication of a manuscript comparing the clinical and economic impact of percutaneous ventricular assist devices (pVAD) with intraaortic balloon...